-+ 0.00%
-+ 0.00%
-+ 0.00%

Sanofi takes 26.4% stake in Cheplapharm in mature medicines partnership

PUBT·09/14/2026 13:58:38
Listen to the news
Sanofi takes 26.4% stake in Cheplapharm in mature medicines partnership
  • Sanofi agreed to take a 26.4% equity stake in Cheplapharm as part of a planned mature-medicines strategic partnership.
  • Equity investment tied to Cheplapharm’s takeover of 20 mature medicines from Sanofi, including Lovenox/Clexane, excluding the US.
  • Transaction also covers the planned transfer of three manufacturing sites in Hungary, Singapore, France, with completion targeted by Q3 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cheplapharm AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2398918_en) on September 14, 2026, and is solely responsible for the information contained therein.